Researchers at Utah State University, led by Professor Zhongde Wang and collaborating with teams at University of Texas Medical Branch and University of Pittsburgh, respectively, have secured two grants from the National Institutes of Health (NIH) totaling more than $4 million in recent months to advance the understanding of two important global health threats. In […]
BioUtah and five BioUtah member companies participated in the Governor’s trade mission to Korea and Japan organized by World Trade Center Utah. Led by BioUtah president and CEO, Kelvyn Cullimore, the life sciences delegation included Dwight Egan, Seth Egan and Richard Abbott of CoDiagnostics, Mike Kirkness and Lucas Bennink of 3Helix, Taylor Avei of Halia […]
SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor’s Office of Economic Opportunity, as part of the latest World Trade Center (WTC) Utah trade […]
BioUtah’s annual membership appreciation BBQ was held yesterday at the Gateway’s Hidden Gem Patio. The event was a great way for the nearly 200 registrants to network with colleagues and make new connections. Prior to the BBQ, an executive reception was held, with several BioUtah Board members present. Also, in conjunction with the BBQ, the […]
BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.
[…]
Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to even more parents across the globe. […]
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. […]
Edwards Lifesciences announced the results from the RHEIA Trial. […]
Halia Therapeutics’ CEO, David Bearss, recently discussed the FDA’s Project Optimus in The Wall Street Journal. […]
SPRINGVILLE, UT, UNITED STATES, August 26, 2024 /EINPresswire.com/ — ATL Technology, a global leader in medical device development and manufacturing, announced today its acquisition of MDCM Solutions, a Minnesota manufacturing company specializing in complex catheter technologies used in the manufacture of minimally invasive medical devices. The newly acquired ATL Minnesota site will serve as a […]
CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION […]
Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials, is announcing acquisition of Medicinos Linija UAB, known globally as “i-dental,” a renowned manufacturer and distributer of dental products headquartered in Siauliai, Lithuania. The addition of i-dental’s network and infrastructure will assist Ultradent’s ability to better serve dentists throughout the world. With i-dental […]